18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
2019 · Diagnostic and Interventional Imaging · 32 citations
https://doi.org/10.1016/j.diii.2019.07.006
M
Myriam Wartski
Hôpital Cochin(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.2K
Citations
22
h-index
30
i10-index
Myriam Wartski is an academic researcher from Hôpital Cochin. The author has contributed to research in topics: Medical Imaging Techniques and Applications & Radiomics and Machine Learning in Medical Imaging & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 22, co-authored 84 publications.
ORCID: 0000-0002-6325-1451Papers by this author
works[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
2025 · The Lancet. Gastroenterology & hepatology · 4 citations
https://doi.org/10.1016/s2468-1253(25)00011-1
OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)00518-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat